<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37730817</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Cluster analysis driven by unsupervised latent feature learning of medications to identify novel pharmacophenotypes of critically ill patients.</ArticleTitle><Pagination><StartPage>15562</StartPage><MedlinePgn>15562</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-42657-2</ELocationID><Abstract><AbstractText>Unsupervised clustering of intensive care unit (ICU) medications may identify unique medication clusters (i.e., pharmacophenotypes) in critically ill adults. We performed an unsupervised analysis with Restricted Boltzmann Machine of 991 medications profiles of patients managed in the ICU to explore pharmacophenotypes that correlated with ICU complications (e.g., mechanical ventilation) and patient-centered outcomes (e.g., length of stay, mortality). Six unique pharmacophenotypes were observed, with unique medication profiles and clinically relevant differences in ICU complications and patient-centered outcomes. While pharmacophenotypes 2 and 4 had no statistically significant difference in ICU length of stay, duration of mechanical ventilation, or duration of vasopressor use, their mortality differed significantly (9.0% vs. 21.9%, p&#x2009;&lt;&#x2009;0.0001). Pharmacophenotype 4 had a mortality rate of 21.9%, compared with the rest of the pharmacophenotypes ranging from 2.5 to 9%. Phenotyping approaches have shown promise in classifying the heterogenous syndromes of critical illness to predict treatment response and guide clinical decision support systems but have never included comprehensive medication information. This first-ever machine learning approach revealed differences among empirically-derived subgroups of ICU patients that are not typically revealed by traditional classifiers. Identification of pharmacophenotypes may enable enhanced decision making to optimize treatment decisions.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sikora</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Augusta, GA, USA. sikora@uga.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Hayoung</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Georgia Institute of Technology, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Mengyun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Georgia Franklin College of Arts and Sciences, Athens, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xianyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Georgia Franklin College of Arts and Sciences, Athens, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamaleswaran</LastName><ForeName>Rishikesan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1R21HS028485</GrantID><Agency>Agency for Healthcare Research and Quality</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>23</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37730817</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-42657-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-42657-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Newsome, A. S. et al. Optimization of critical care pharmacy clinical services: A gap analysis approach. Am. J. Health Syst. Pharm. 78, 2077&#x2013;2085 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34061960</ArticleId><ArticleId IdType="pmc">8195049</ArticleId><ArticleId IdType="doi">10.1093/ajhp/zxab237</ArticleId></ArticleIdList></Reference><Reference><Citation>Lat, I. et al. Position paper on critical care pharmacy services: 2020 Update. Crit. Care Med. 48, e813&#x2013;e834 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32826496</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000004437</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay, M. A. et al. Acute respiratory distress syndrome. Nat. Rev. Dis. Primers 5, 18 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30872586</ArticleId><ArticleId IdType="pmc">6709677</ArticleId><ArticleId IdType="doi">10.1038/s41572-019-0069-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Leligdowicz, A. &amp; Matthay, M. A. Heterogeneity in sepsis: New biological evidence with clinical applications. Crit. Care 23, 80 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30850013</ArticleId><ArticleId IdType="pmc">6408778</ArticleId><ArticleId IdType="doi">10.1186/s13054-019-2372-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott, H. C., Calfee, C. S., Thompson, B. T., Angus, D. C. &amp; Liu, V. X. Toward smarter lumping and smarter splitting: Rethinking strategies for sepsis and acute respiratory distress syndrome clinical trial design. Am. J. Respir. Crit. Care Med. 194, 147&#x2013;155 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27244481</ArticleId><ArticleId IdType="pmc">5003218</ArticleId><ArticleId IdType="doi">10.1164/rccm.201512-2544CP</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen, J. et al. Sepsis: A roadmap for future research. Lancet Infect. Dis. 15, 581&#x2013;614 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25932591</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(15)70112-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, L. et al. Five novel clinical phenotypes for critically ill patients with mechanical ventilation in intensive care units: A retrospective and multi database study. Respir. Res. 21, 325 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33302940</ArticleId><ArticleId IdType="pmc">7727781</ArticleId><ArticleId IdType="doi">10.1186/s12931-020-01588-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipanah, N. &amp; Calfee, C. S. Phenotyping in acute respiratory distress syndrome: State of the art and clinical implications. Curr. Opin. Crit. Care 28, 1&#x2013;8 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34670998</ArticleId><ArticleId IdType="pmc">8782441</ArticleId><ArticleId IdType="doi">10.1097/MCC.0000000000000903</ArticleId></ArticleIdList></Reference><Reference><Citation>Messmer, A. S. et al. Fluid overload phenotypes in critical illness: A machine learning approach. J. Clin. Med. 11, 336 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35054030</ArticleId><ArticleId IdType="pmc">8780174</ArticleId><ArticleId IdType="doi">10.3390/jcm11020336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao, L. et al. A Survey on causal inference. ACM Trans. Knowledge Discovery from Data (TKDD) (2021).</Citation></Reference><Reference><Citation>Churpek, M. M. et al. Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Crit. Care Med. 44, 368&#x2013;374 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26771782</ArticleId><ArticleId IdType="pmc">4736499</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000001571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ginestra, J. C. et al. Clinician perception of a machine learning-based early warning system designed to predict severe sepsis and septic shock. Crit. Care Med. 47, 1477&#x2013;1484 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31135500</ArticleId><ArticleId IdType="pmc">6791738</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000003803</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyner, J. L., Carey, K. A., Edelson, D. P. &amp; Churpek, M. M. The development of a machine learning inpatient acute kidney injury prediction model. Crit. Care Med. 46, 1070&#x2013;1077 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29596073</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000003123</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, R., Greenstein, J. L., Fackler, J. C., Bembea, M. M. &amp; Winslow, R. L. Spectral clustering of risk score trajectories stratifies sepsis patients by clinical outcome and interventions received. Elife 9, 58142 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.58142</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunwell, J. R. et al. Cluster analysis and profiling of airway fluid metabolites in pediatric acute hypoxemic respiratory failure. Sci. Rep 11, 23019 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34836982</ArticleId><ArticleId IdType="pmc">8626441</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-02354-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Holder, A. L., Shashikumar, S. P., Wardi, G., Buchman, T. G. &amp; Nemati, S. A locally optimized data-driven tool to predict sepsis-associated vasopressor use in the ICU. Crit. Care Med. 49, e1196&#x2013;e1205 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34259450</ArticleId><ArticleId IdType="pmc">8602707</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000005175</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal, L. et al. eARDS: A multi-center validation of an interpretable machine learning algorithm of early onset Acute Respiratory Distress Syndrome (ARDS) among critically ill adults with COVID-19. PLoS ONE 16, e0257056 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34559819</ArticleId><ArticleId IdType="pmc">8462682</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0257056</ArticleId></ArticleIdList></Reference><Reference><Citation>Practices, I.o.S.M. High Alert Medications (2018).</Citation></Reference><Reference><Citation>Maslove, D. M., Lamontagne, F., Marshall, J. C. &amp; Heyland, D. K. A path to precision in the ICU. Crit. Care 21, 79 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28366166</ArticleId><ArticleId IdType="pmc">5376689</ArticleId><ArticleId IdType="doi">10.1186/s13054-017-1653-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern, N. A., Goldman, D. A., Tan, K. S. &amp; Pastores, S. M. Trends in critical care beds and use among population groups and medicare and medicaid beneficiaries in the United States: 2000&#x2013;2010. Crit. Care Med. 44, 1490&#x2013;1499 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27136721</ArticleId><ArticleId IdType="pmc">5520973</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000001722</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen, D. J. et al. Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units. Crit. Care Med. 25, 1289&#x2013;1297 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9267940</ArticleId><ArticleId IdType="doi">10.1097/00003246-199708000-00014</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, D., Ngo, B. &amp; van Sonnenberg, E. AI in the intensive care unit: Up-to-date review. J. Intensive Care Med. 36, 1115&#x2013;1123 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32985324</ArticleId><ArticleId IdType="doi">10.1177/0885066620956620</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhya, V. &amp; Sastry, P. S. Learning Gaussian-Bernoulli RBMs using difference of convex functions optimization. IEEE Trans. Neural Netw. and Learn. Syst. https://doi.org/10.1109/TNNLS.2021.3071358 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TNNLS.2021.3071358</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe, I. Principal component analysis. In International Encyclopedia of Statistical Science (ed. Lovric, M.) (Springer, 2014).</Citation></Reference><Reference><Citation>Hinton, G. E. A practical guide to training restricted Boltzmann machines. In Neural Networks: Tricks of the Trade 2nd edn 599&#x2013;619 (Springer, 2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-642-35289-8_32</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwin, C. Restricted-boltzmann-machines. GitHub Repository. https://github.com/echen/restricted-boltzmann-machines .</Citation></Reference><Reference><Citation>Murtagh, F. &amp; Legendre, P. Ward&#x2019;s hierarchical agglomerative clustering method: Which algorithms implement ward&#x2019;s criterion?. J. Classif. 31, 274&#x2013;295. https://doi.org/10.1007/s00357-014-9161-z (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00357-014-9161-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson, M. J. A new method for non-parametric multivariate analysis of variance. Austral. Ecol. 26, 32&#x2013;46. https://doi.org/10.1111/j.1442-9993.2001.01070.pp.x (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-9993.2001.01070.pp.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel, R. B. et al. Association of longitudinal trajectory of albuminuria in young adulthood with myocardial structure and function in later life: Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA Cardiol. 5(2), 184&#x2013;192 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">6865313</ArticleId><ArticleId IdType="doi">10.1001/jamacardio.2019.4867</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour, C. W. et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA 321(20), 2003&#x2013;2017. https://doi.org/10.1001/jama.2019.5791 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.5791</ArticleId><ArticleId IdType="pubmed">31104070</ArticleId><ArticleId IdType="pmc">6537818</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy, K., Calfee, C. S. &amp; McAuley, D. F. Acute respiratory distress syndrome subphenotypes beyond the syndrome: A step toward treatable traits?. Am. J. Respir. Crit. Care Med. 203(12), 1449&#x2013;1451 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33565943</ArticleId><ArticleId IdType="pmc">8483225</ArticleId><ArticleId IdType="doi">10.1164/rccm.202101-0218ED</ArticleId></ArticleIdList></Reference><Reference><Citation>Lezhnina, O. &amp; Kismih&#xf3;k, G. Latent class cluster analysis: Selecting the number of clusters. MethodsX 9, 101747 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35712641</ArticleId><ArticleId IdType="pmc">9192797</ArticleId><ArticleId IdType="doi">10.1016/j.mex.2022.101747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori, M., Krumholz, H. M. &amp; Allore, H. G. Using latent class analysis to identify hidden clinical phenotypes. JAMA 324(7), 700&#x2013;701. https://doi.org/10.1001/jama.2020.2278 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2278</ArticleId><ArticleId IdType="pubmed">32808993</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant, R. W. et al. Use of latent class analysis and k-means clustering to identify complex patient profiles. JAMA Netw. Open 3(12), e2029068. https://doi.org/10.1001/jamanetworkopen.2020.29068 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.29068</ArticleId><ArticleId IdType="pubmed">33306116</ArticleId><ArticleId IdType="pmc">7733156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ospina-Tascon, G. A., Buchele, G. L. &amp; Vincent, J. L. Multicenter, randomized, controlled trials evaluating mortality in intensive care: Doomed to fail?. Crit. Care Med. 36, 1311&#x2013;1322 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18379260</ArticleId><ArticleId IdType="doi">10.1097/CCM.0b013e318168ea3e</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli, A. R., Zein, J., Adams, J. &amp; Ioannidis, J. P. Effects of interventions on survival in acute respiratory distress syndrome: An umbrella review of 159 published randomized trials and 29 meta-analyses. Intensive Care Med. 40, 769&#x2013;787 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24667919</ArticleId><ArticleId IdType="pmc">4031289</ArticleId><ArticleId IdType="doi">10.1007/s00134-014-3272-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffey, J. G. &amp; Kavanagh, B. P. Negative trials in critical care: why most research is probably wrong. Lancet Respir. Med. 6, 659&#x2013;660 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30061048</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(18)30279-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Leo, G. &amp; Sardanelli, F. Statistical significance: p value, 0.05 threshold, and applications to radiomics-reasons for a conservative approach. Eur. Radiol. Exp. 4, 18 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32157489</ArticleId><ArticleId IdType="pmc">7064671</ArticleId><ArticleId IdType="doi">10.1186/s41747-020-0145-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis, A. J., Seymour, C. W. &amp; Rosengart, M. R. Current murine models of sepsis. Surg. Infect. (Larchmt) 17, 385&#x2013;393 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27305321</ArticleId><ArticleId IdType="doi">10.1089/sur.2016.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins, W. A. et al. Fluid stewardship during critical illness: A call to action. J. Pharm. Pract. 33, 863&#x2013;873 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31256705</ArticleId><ArticleId IdType="doi">10.1177/0897190019853979</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, J. Drug-induced nephrotoxicity and drug metabolism in renal failure. Curr. Drug Metab. 19, 558 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30009693</ArticleId><ArticleId IdType="doi">10.2174/138920021907180709121120</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin, J. W. et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit. Care Med. 46, e825&#x2013;e873 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30113379</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000003299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, H. et al. Impact on patient outcomes of pharmacist participation in multidisciplinary critical care teams: A systematic review and meta-analysis. Crit. Care Med. 47, 1243&#x2013;1250 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31135496</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000003830</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfee, C. S. et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: Secondary analysis of a randomised controlled trial. Lancet Respir. Med. 6, 691&#x2013;698 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30078618</ArticleId><ArticleId IdType="pmc">6201750</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(18)30177-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Famous, K. R. et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am. J. Respir. Crit. Care Med. 195, 331&#x2013;338 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27513822</ArticleId><ArticleId IdType="pmc">5328179</ArticleId><ArticleId IdType="doi">10.1164/rccm.201603-0645OC</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour, C. W. et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA 321, 2003&#x2013;2017 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31104070</ArticleId><ArticleId IdType="pmc">6537818</ArticleId><ArticleId IdType="doi">10.1001/jama.2019.5791</ArticleId></ArticleIdList></Reference><Reference><Citation>Geri, G. et al. Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: A post hoc analysis. Intensive Care Med. 45, 657&#x2013;667 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30888443</ArticleId><ArticleId IdType="doi">10.1007/s00134-019-05596-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikora, A. et al. Evaluation of medication regimen complexity as a predictor for mortality. Sci. Rep. 13(1), 10784. https://doi.org/10.1038/s41598-023-37908-1 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-37908-1</ArticleId><ArticleId IdType="pubmed">37402869</ArticleId><ArticleId IdType="pmc">10319715</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mamun, M. A., Brothers, T. &amp; Newsome, A. S. Development of machine learning models to validate a medication regimen complexity scoring tool for critically ill patients. Ann. Pharmacother. 55, 421&#x2013;429 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32929977</ArticleId><ArticleId IdType="doi">10.1177/1060028020959042</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwynn, M. E., Poisson, M. O., Waller, J. L. &amp; Newsome, A. S. Development and validation of a medication regimen complexity scoring tool for critically ill patients. Am. J. Health Syst. Pharm. 76, S34&#x2013;S40 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31067298</ArticleId><ArticleId IdType="doi">10.1093/ajhp/zxy054</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome, A. S., Anderson, D., Gwynn, M. E. &amp; Waller, J. L. Characterization of changes in medication complexity using a modified scoring tool. Am. J. Health Syst. Pharm. 76, S92&#x2013;S95 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31586396</ArticleId><ArticleId IdType="doi">10.1093/ajhp/zxz213</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome, A. et al. Medication regimen complexity is associated with pharmacist interventions and drug-drug interactions: A use of the novel MRC-ICU scoring tool. J. Am. Coll. Clin. Pharm. 3, 47&#x2013;56 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jac5.1146</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome, A. S., Smith, S. E., Olney, W. J. &amp; Jones, T. W. Multicenter validation of a novel medication-regimen complexity scoring tool. Am. J. Health Syst. Pharm. 77, 474&#x2013;478 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">34086844</ArticleId><ArticleId IdType="doi">10.1093/ajhp/zxz330</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney, W. J., Chase, A. M., Hannah, S. A., Smith, S. E. &amp; Newsome, A. S. Medication regimen complexity score as an indicator of fluid balance in critically ill patients. J. Pharm. Pract. 35, 573&#x2013;579 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33685269</ArticleId><ArticleId IdType="pmc">8426415</ArticleId><ArticleId IdType="doi">10.1177/0897190021999792</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, S. E., Shelley, R. &amp; Newsome, A. S. Medication regimen complexity vs patient acuity for predicting critical care pharmacist interventions. Am. J. Health Syst. Pharm. 79, 651&#x2013;655 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">8975577</ArticleId><ArticleId IdType="doi">10.1093/ajhp/zxab460</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. et al. A survey on truth discovery. ACM SIGKDD Explor. Newsl 17(2), 1&#x2013;16 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2897350.2897352</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>